Manuscript
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Philip M Clarke et al.
Diabetes Care 2025;48:1925-1931
Manuscript
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Ruth L Coleman et al.
Cardiovasc Diabetol. 2025;24:347
Manuscript
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL Substudy
Anthony E. Peters et al.
Sci Rep 2025;15:30170
Manuscript
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study
Pedro Cardoso et al.
Diabetes Obes Metab. 2025;27:4320-4329
Manuscript
Utilization of proteomic surrogates for early detection of unexpected drug benefits
Jessica Chadwick et al.
J Clin Pharmacol. 2025
Manuscript
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis
Erenesto Maddaloni et al.
Diabetes Res Clin Pract. 2025;223:112125